专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08513202B2 Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate 有权
标题翻译： 1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的结晶形式
公开(公告)号：US08513202B2
公开(公告)日：2013-08-20
申请号：US13103557
申请日：2011-05-09
申请人： Sumihiro Nomura , Eiji Kawanishi
发明人： Sumihiro Nomura , Eiji Kawanishi
IPC分类号： A61K31/7034 , C07H7/04
CPC分类号： A61K31/7034 , C07H7/04
摘要： A novel crystal form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra-red spectrum.
摘要翻译： 1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的新晶体形式，具有良好的特性，其特征在于其X-射线粉末衍射图案和/或其红外光谱。

2. 发明申请

US20110105424A1 GLUCOPYRANOSIDE COMPOUND 有权
标题翻译：葡萄糖苷化合物
公开(公告)号：US20110105424A1
公开(公告)日：2011-05-05
申请号：US13005757
申请日：2011-01-13
申请人： Sumihiro NOMURA , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro NOMURA , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： A61K31/70 , C07H19/00 , A61P3/10 , A61P17/02 , A61P7/00 , A61P9/00 , A61P3/04
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

3. 发明申请

US20110212905A1 CRYSTALLINE FORM OF 1-(BETA-D-GLUCOPYRANOSYL)-4-METHYL-3-[5-(4-FLUOROPHENYL)-2-THIENYLMETHYL]BENZENE HEMIHYDRATE 有权
标题翻译： 1-（β-D-吡喃葡糖基）-4-甲基-3- [5-（4-氟苯基）-2-甲苯基]苯甲酸乙酯的晶体形式
公开(公告)号：US20110212905A1
公开(公告)日：2011-09-01
申请号：US13103557
申请日：2011-05-09
申请人： Sumihiro Nomura , Eiji Kawanishi
发明人： Sumihiro Nomura , Eiji Kawanishi
IPC分类号： A61K31/7042 , C07H7/06 , A61P3/10 , A61P3/06 , A61P17/02 , A61P3/04 , A61P9/10 , A61P9/12
CPC分类号： A61K31/7034 , C07H7/04
摘要： A novel crystal form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra-red spectrum.
摘要翻译：具有良好特性的1 - （＆bgr。-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的新晶体形式的特征在于其X-射线粉末衍射图案和/或其红外光谱。

4. 发明授权

US07943788B2 Glucopyranoside compound 有权
标题翻译：吡喃葡萄糖苷化合物
公开(公告)号：US07943788B2
公开(公告)日：2011-05-17
申请号：US11045446
申请日：2005-01-31
申请人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： C07D409/00 , A01N43/04 , C07D277/04 , C07D277/08 , C07D487/00 , C07D257/04 , C07D257/10 , C07D403/00
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 其药学上可接受的盐或其前药。

5. 发明申请

US20050233988A1 Novel compounds 有权
标题翻译：新型化合物
公开(公告)号：US20050233988A1
公开(公告)日：2005-10-20
申请号：US11045446
申请日：2005-01-31
申请人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： A61K31/7072 , C07H19/048 , C07H19/06
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y是 - （CH 2）n - （n是1或2）; 其药学上可接受的盐或其前药。

6. 发明申请

US20120058941A1 GLUCOPYRANOSIDE COMPOUND 有权
标题翻译：葡萄糖苷化合物
公开(公告)号：US20120058941A1
公开(公告)日：2012-03-08
申请号：US13174814
申请日：2011-07-01
申请人： Sumihiro NOMURA , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro NOMURA , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： A61K31/7034 , A61K38/28 , A61K38/26 , A61P3/10 , A61P27/02 , A61P25/02 , A61P13/12 , A61P17/02 , A61P5/48 , A61P7/00 , A61P3/06 , A61P3/04 , A61P3/00 , A61P9/10 , A61P9/12 , A61P7/02 , A61K31/7056
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

7. 发明申请

US20080146515A1 Crystalline form of 1-(beta-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate 有权
标题翻译： 1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的结晶形式
公开(公告)号：US20080146515A1
公开(公告)日：2008-06-19
申请号：US11987670
申请日：2007-12-03
申请人： Sumihiro Nomura , Eiji Kawanishi
发明人： Sumihiro Nomura , Eiji Kawanishi
IPC分类号： A61K31/7042 , C07H7/06 , A61P3/12 , A61P3/06 , A61P3/00
CPC分类号： A61K31/7034 , C07H7/04
摘要： A novel crystal form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate, and having favorable characteristics, is characterized by its x-ray powder diffraction pattern and/or by its infra-red spectrum.
摘要翻译： 1-（β-D-吡喃葡萄糖基）-4-甲基-3- [5-（4-氟苯基）-2-噻吩甲基]苯半水合物的新晶体形式，具有良好的特性，其特征在于其X-射线粉末衍射图案和/或其红外光谱。

8. 发明授权

US08785403B2 Glucopyranoside compound 有权
标题翻译：吡喃葡萄糖苷化合物
公开(公告)号：US08785403B2
公开(公告)日：2014-07-22
申请号：US13494602
申请日：2012-06-12
申请人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： C07H5/02 , A01N43/04 , A61K31/70
CPC分类号： C07H19/056 , A61K31/7042 , A61K31/7056 , A61K38/24 , A61K38/28 , A61K45/06 , C07H7/04 , C07H7/06 , C07H19/04 , C07H19/044 , C07H19/048 , A61K2300/00
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

9. 发明授权

US08222219B2 Glucopyranoside compound 有权
公开(公告)号：US08222219B2
公开(公告)日：2012-07-17
申请号：US13174814
申请日：2011-07-01
申请人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： A01N43/04 , A61K31/70
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.

10. 发明授权

US08202984B2 Glucopyranoside compound 有权
标题翻译：吡喃葡萄糖苷化合物
公开(公告)号：US08202984B2
公开(公告)日：2012-06-19
申请号：US13005757
申请日：2011-01-13
申请人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
发明人： Sumihiro Nomura , Eiji Kawanishi , Kiichiro Ueta
IPC分类号： C07H19/00 , C07H19/22 , C07H19/048 , C07H19/056 , A01N43/04 , A61K31/70 , C07H19/06
CPC分类号： C07H19/048 , A61K45/06 , C07D405/04 , C07D409/04 , C07D409/10 , C07H19/06
摘要： A compound of the formula: wherein Ring A and Ring B are: (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring or an optionally substituted unsaturated fused heterobicyclic ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, and Ring B are independently an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; X is a carbon atom or a nitrogen atom; Y is —(CH2)n— (n is 1 or 2); or a pharmaceutically acceptable salt thereof, or a prodrug thereof.
摘要翻译：下式的化合物：其中环A和环B是：（1）环A是任选取代的不饱和单环杂环，环B是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环，或任选取代的苯环，（2）环A是任选取代的苯环，环B是任选取代的不饱和单环杂环或任选取代的不饱和稠环杂双环，或（3）环A是任选取代的不饱和稠合杂双环环和环B独立地是任选取代的不饱和单环杂环，任选取代的不饱和稠合杂双环或任选取代的苯环; X是碳原子或氮原子; Y为 - （CH 2）n - （n为1或2）; 或其药学上可接受的盐，或其前药。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式